Overview

Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer

Status:
Completed

Trial end date:
2007-06-01

Target enrollment:

Participant gender:

Summary

The optimal strategy in advanced non small cell lung cancer with stable disease is not well known. There is no published study assessing an early change of chemotherapeutic drugs in these patients.Accordingly, we conduct this trial with the objective to improve the rate of objective responses by the switch to another doublet after 2 cycles of CDDP-gemcitabine association for patients with stable diseases (SD).

Phase:

Phase 2

Details

Lead Sponsor:

University Hospital, Limoges

Collaborator:

Groupe Français de Pneumologie Cancérologie (GFPC)

Treatments:

Cisplatin
Gemcitabine